Table 5.

Odds ratio of lipid testing for SLE and DM compared to general Medicaid population, overall and stratified by age groups and baseline CVD status

		General Medicaid	SLE	DM
	N	(Reference)	OR (95% CI)	OR (95% CI)
Overall	181,650	1.0	0.96 (0.92–1.00)	2.79 (2.71–2.87)
Age 18–39	81,615	1.0	1.31 (1.23–1.40)	4.22 (4.02–4.44)
Age 40–49	51,200	1.0	0.83 (0.78–0.89)	2.39 (2.26–2.51)
Age 50–65	48,835	1.0	0.77 (0.71–0.82)	1.89 (1.80–2.00)
Excluding baseline CVD	166,752	1.0	0.98 (0.94–1.03)	2.98 (2.89–3.07)
With baseline CVD	14,898	1.0	0.55 (0.49–0.61)	1.26 (1.15–1.38)

Conditional multivariable logistic regressions with all three cohorts (SLE, DM, general Medicaid population) combined, adjusted for age, sex, race, U.S. region of residence, socioeconomic status, # outpatient visits, # medications, Charlson comorbidity index, presence of CVD, lupus nephritis/diabetic nephropathy—overall, stratified by age groups, and by baseline CVD status (did not adjust for presence of CVD when stratified by baseline CVD status).

Abbreviations: SLE, systemic lupus erythematosus; DM, diabetes mellitus; CVD, cardiovascular disease; OR, odds ratio